PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAxsome Therapeutics
Axsome Therapeutics(AXSM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AuvelityDextromethorphan, Bupropion2022-08-182023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Toothache
,
Dysmenorrhea
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rizatriptan
migraine disorders
Dextromethorphan
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
,
dyskinesias
,
psychomotor agitation
,
neuralgia
,
migraine disorders
,
disease progression
,
sclerosis
,
parkinson disease
,
multiple sclerosis
,
amyotrophic lateral sclerosis
,
pain
,
diabetic neuropathies
,
motor neuron disease
,
pseudobulbar palsy
,
alzheimer disease
,
stroke
,
traumatic brain injuries
,
brain injuries
,
dementia
Bupropion
healthy volunteers/patients
Meloxicam
healthy volunteers/patients
Bupropion hydrochloride
healthy volunteers/patients
Glutamic acid
colorectal neoplasms
Doconexent
prostatic neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
melanoma
Esreboxetine
hyperalgesia
,
fibromyalgia
Reboxetine
narcolepsy
,
cataplexy
,
sleepiness
,
disorders of excessive somnolence
D-glutamate
schizophrenia
,
psychotic disorders
Buproprion
depression
,
treatment-resistant depressive disorder
,
major depressive disorder
,
depressive disorder
Nicoderm
tobacco use disorder
,
cigarette smoking
,
smoking cessation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use